RPG Investment Advisory’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-267,624
Closed -$4.96M 313
2018
Q1
$4.96M Buy
267,624
+6,504
+2% +$96.2K 1.13% 35
2017
Q4
$3.75M Buy
261,120
+26,836
+11% +$349K 0.91% 45
2017
Q3
$2.87M Buy
234,284
+3,224
+1% +$57K 0.73% 51
2017
Q2
$4.23M Buy
231,060
+67,164
+41% +$1.24M 1.16% 35
2017
Q1
$3.47M Buy
163,896
+4,584
+3% +$89.5K 1.02% 41
2016
Q4
$2.38M Buy
159,312
+2,740
+2% +$48.5K 0.8% 48
2016
Q3
$3.43M Sell
156,572
-25,844
-14% -$575K 1.07% 39
2016
Q2
$3.62M Buy
182,416
+97,180
+114% +$1.65M 0.97% 42
2016
Q1
$1.45M Sell
85,236
-1,508
-2% -$25.2K 0.56% 60
2015
Q4
$1.78M Buy
+86,744
New +$1.8M 0.66% 55

Other funds holding DXCM

RPG Investment Advisory's DXCM Position: Q2 2018 in Review

RPG Investment Advisory sold out of DexCom (DXCM) in Q2 2018, closing a stake of 267,624 shares — an estimated $4.96M sold.

RPG Investment Advisory first reported a position in DXCM in Q4 2015 and held it in 10 quarters. The position peaked at $4.96M in Q1 2018. 290 funds tracked by Wall St. Rank hold DXCM as of Q2 2018.

  • RPG Investment Advisory reported no remaining DexCom position as of Q2 2018 after selling out during the quarter.
  • RPG Investment Advisory sold 267,624 DexCom shares in Q2 2018, an estimated $4.96M.
  • RPG Investment Advisory first reported a position in DexCom in Q4 2015 and held it in 10 quarters.
  • RPG Investment Advisory's DexCom position peaked at $4.96M in Q1 2018.
  • 290 funds tracked by Wall St. Rank held DexCom as of Q2 2018.

Based on RPG Investment Advisory's 13F filing for Q2 2018, filed 6 Aug 2018.